Long-term follow-up results of TOURMALINE-MM2: IRd vs pbo-Rd in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:22 2 years ago 86 Скачать Далее
Long-term follow-up of the TOURMALINE-MM1 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 29 Скачать Далее
TOURMALINE-MM2: Clinically Meaningful Results in Multiple Myeloma Trial CheckRare 7:19 3 years ago 47 Скачать Далее
Long term follow-up results from the Phase III MAIA trial in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:08 3 years ago 238 Скачать Далее
Final Analysis of the Phase 3 TOURMALINE-MM1: Ixazomib + Lenalidomide-Dex Vs Placebo-Rd in RRMM International Myeloma Foundation 7:11 3 years ago 503 Скачать Далее
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 2:36 7 years ago 410 Скачать Далее
Long-Term Efficacy of Daratumumab-Based Regimen in Multiple Myeloma CheckRare 7:32 1 year ago 478 Скачать Далее
TOURMALINE-MM1: Benefit of IRd Triplet for R/R MM Targeted Oncology 5:29 5 years ago 245 Скачать Далее
Predicting long-term outcomes in myeloma: MRD VJHemOnc – Video Journal of Hematology & HemOnc 2:44 6 years ago 27 Скачать Далее
Long-term follow-up from the UK Myeloma XI trial VJHemOnc – Video Journal of Hematology & HemOnc 2:06 4 years ago 139 Скачать Далее
Overview of the final analysis of the Phase III TOURMALINE-MM1 trial VJHemOnc – Video Journal of Hematology & HemOnc 4:48 3 years ago 126 Скачать Далее
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 7:15 8 years ago 154 Скачать Далее
Ultra-Sensitive Assessment of MRD in Peripheral Blood of Multiple Myeloma Patients Using Bloodflow International Myeloma Foundation 9:53 1 year ago 341 Скачать Далее
Results of the Phase 2 IFM 2018-04 Study in High-Risk, Transplant-Eligible NDMM Patients International Myeloma Foundation 5:54 2 years ago 436 Скачать Далее
What treatment is recommended for a newly diagnosed patient? International Myeloma Foundation 3:43 1 year ago 1 056 Скачать Далее
Post-hoc analysis of TOURMALINE-MM1 data while adjusting for subsequent therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:33 3 months ago 35 Скачать Далее
TOURMALINE-MM3 and 4: Ixazomib as Maintenance Therapy in Myeloma Patients American Society of Hematology 4:19 8 years ago 679 Скачать Далее
Measurable Residual Disease Evaluation During Ixazomib Maintenance in NDMM: TOURMALINE-MM3 and -MM4 International Myeloma Foundation 9:57 3 years ago 198 Скачать Далее
